Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors

BACKGROUND: Local ablative treatments improve survival in patients with oligometastatic disease in addition to chemotherapy. The application of immune checkpoint inhibitors prolonged patients’ survival in different tumor entities. This raises the question if patients still benefit from intensified l...

Descripción completa

Detalles Bibliográficos
Autores principales: Schubert, Philipp, Rutzner, Sandra, Eckstein, Markus, Frey, Benjamin, Schweizer, Claudia, Haderlein, Marlen, Lettmaier, Sebastian, Semrau, Sabine, Gostian, Antoniu-Oreste, Zhou, Jian-Guo, Gaipl, Udo S., Fietkau, Rainer, Hecht, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673414/
https://www.ncbi.nlm.nih.gov/pubmed/33251140
http://dx.doi.org/10.3389/fonc.2020.576643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673414/
https://www.ncbi.nlm.nih.gov/pubmed/33251140
http://dx.doi.org/10.3389/fonc.2020.576643

Ejemplares similares